| Title : Rivastigmine augmentation in the management of chronic schizophrenia with comorbid dementia: an open-label study investigating effects on cognition, behaviour and activities of daily living - Mendelsohn_2004_Int.Clin.Psychopharmacol_19_319 |
| Author(s) : Mendelsohn E , Rosenthal M , Bohiri Y , Werber E , Kotler M , Strous RD |
| Ref : Int Clin Psychopharmacol , 19 :319 , 2004 |
| Abstract : Mendelsohn_2004_Int.Clin.Psychopharmacol_19_319 |
| ESTHER : Mendelsohn_2004_Int.Clin.Psychopharmacol_19_319 |
| PubMedSearch : Mendelsohn_2004_Int.Clin.Psychopharmacol_19_319 |
| PubMedID: 15486516 |
Mendelsohn E, Rosenthal M, Bohiri Y, Werber E, Kotler M, Strous RD (2004)
Rivastigmine augmentation in the management of chronic schizophrenia with comorbid dementia: an open-label study investigating effects on cognition, behaviour and activities of daily living
Int Clin Psychopharmacol
19 :319
Mendelsohn E, Rosenthal M, Bohiri Y, Werber E, Kotler M, Strous RD (2004)
Int Clin Psychopharmacol
19 :319